16 June 2020>: Clinical Research
Effects of Valsartan on Restenosis in Patients with Arteriosclerosis Obliterans of the Lower Extremities Undergoing Interventional Therapy: A Prospective, Randomized, Single-Blind Trial
Wei Yao 1ABE , Lixin Wang 2AB* , Qing Chen 1BC , Fang Wang 1CD , Nana Feng 1EFDOI: 10.12659/MSM.919977
Med Sci Monit 2020; 26:e919977
Table 4 Comparison of ABI and the levels of hs-CRP and IL-in the 2 groups.
No. of patients | Before the surgery | 6 months after the surgery | t | P | ||
---|---|---|---|---|---|---|
hs-CRP, mg·L | ARB group | 98 | 9.60±2.56 | 3.93±1.43 | −9.780 | 0.001 |
Control group | 96 | 10.31±3.12 | 7.27±1.67 | |||
IL-6, Ng·L | ARB group | 98 | 26.45±5.23 | 11.26±2.29 | −3.420 | 0.000 |
Control group | 96 | 27.12±3.12 | 16.74±1.90 | |||
ABI | ARB group | 98 | 0.61±0.59 | 0.98±0.20 | 6.230 | 0.001 |
Control group | 96 | 0.58±0.71 | 0.62±0.48 | |||